Victory Capital Management Inc. increased its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 0.6% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 75,215 shares of the medical equipment provider’s stock after purchasing an additional 471 shares during the period. Victory Capital Management Inc. owned 0.07% of Intuitive Surgical worth $42,916,000 as of its most recent SEC filing.
Other hedge funds also recently bought and sold shares of the company. Buffington Mohr McNeal bought a new position in Intuitive Surgical in the 1st quarter worth approximately $86,000. Mn Services Vermogensbeheer B.V. raised its position in Intuitive Surgical by 7.2% in the 4th quarter. Mn Services Vermogensbeheer B.V. now owns 19,288 shares of the medical equipment provider’s stock worth $8,081,000 after purchasing an additional 1,300 shares during the last quarter. Stevens Capital Management LP bought a new position in Intuitive Surgical in the 4th quarter worth approximately $6,786,000. Sigma Planning Corp raised its position in Intuitive Surgical by 4.8% in the 4th quarter. Sigma Planning Corp now owns 3,270 shares of the medical equipment provider’s stock worth $1,566,000 after purchasing an additional 149 shares during the last quarter. Finally, Larson Financial Group LLC bought a new position in Intuitive Surgical in the 4th quarter worth approximately $91,000. Hedge funds and other institutional investors own 84.85% of the company’s stock.
Shares of ISRG stock traded up $5.88 on Thursday, hitting $493.23. The stock had a trading volume of 253,373 shares, compared to its average volume of 781,577. Intuitive Surgical, Inc. has a twelve month low of $430.24 and a twelve month high of $589.32. The firm has a market capitalization of $57.15 billion, a price-to-earnings ratio of 51.97, a price-to-earnings-growth ratio of 4.18 and a beta of 1.02.
Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Thursday, April 18th. The medical equipment provider reported $2.61 EPS for the quarter, missing the consensus estimate of $2.70 by ($0.09). The company had revenue of $974.00 million during the quarter, compared to the consensus estimate of $975.27 million. Intuitive Surgical had a net margin of 29.78% and a return on equity of 17.33%. The company’s revenue was up 14.9% compared to the same quarter last year. During the same period in the prior year, the firm posted $2.44 earnings per share. Sell-side analysts predict that Intuitive Surgical, Inc. will post 9.4 earnings per share for the current year.
In related news, CEO Gary S. Guthart sold 22,636 shares of the business’s stock in a transaction on Monday, May 6th. The shares were sold at an average price of $501.48, for a total value of $11,351,501.28. Following the sale, the chief executive officer now directly owns 386,866 shares of the company’s stock, valued at approximately $194,005,561.68. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP Curet Myriam sold 2,200 shares of the business’s stock in a transaction on Tuesday, April 23rd. The shares were sold at an average price of $493.26, for a total transaction of $1,085,172.00. Following the completion of the sale, the executive vice president now directly owns 3,101 shares in the company, valued at $1,529,599.26. The disclosure for this sale can be found here. Insiders sold a total of 32,266 shares of company stock worth $16,451,271 over the last ninety days. 1.70% of the stock is currently owned by insiders.
ISRG has been the subject of a number of analyst reports. Citigroup lowered their target price on shares of Intuitive Surgical from $611.00 to $575.00 and set a “buy” rating for the company in a report on Tuesday. Zacks Investment Research lowered shares of Intuitive Surgical from a “hold” rating to a “sell” rating in a report on Wednesday, April 24th. Raymond James lowered their target price on shares of Intuitive Surgical from $630.00 to $610.00 and set an “outperform” rating for the company in a report on Monday, April 22nd. Canaccord Genuity reaffirmed a “buy” rating and set a $575.00 target price (down previously from $610.00) on shares of Intuitive Surgical in a report on Monday, April 22nd. Finally, BTIG Research reaffirmed a “hold” rating on shares of Intuitive Surgical in a report on Sunday, April 21st. Two research analysts have rated the stock with a sell rating, four have given a hold rating and fourteen have assigned a buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and an average target price of $576.82.
About Intuitive Surgical
Intuitive Surgical, Inc designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. Its da Vinci Surgical System transforms the surgeon's natural hand movements outside the body into corresponding micro-movements inside the patient's body. The company's da Vinci Surgical System include surgeon's consoles, patient-side carts, 3-D vision systems, da Vinci skills simulators, da Vinci Xi integrated table motions, and Firefly fluorescence imaging products that enable surgeons to perform various surgical procedures, including gynecologic, urologic, general, cardiothoracic, and head and neck surgical procedures.
Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG).
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.